THE LIBERATOR

K984391 · Liberator Wheelchairs, Inc. · IPL · Sep 3, 1999 · Physical Medicine

Device Facts

• Record ID: K984391
• Device Name: THE LIBERATOR
• Applicant: Liberator Wheelchairs, Inc.
• Product Code: IPL · Physical Medicine
• Decision Date: Sep 3, 1999
• Decision: SESE
• Submission Type: Abbreviated
• Regulation: 21 CFR 890.3900
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The Liberator wheelchair will be used for paraplegics to afford them the opportunity to be in a standing position while moving around in the wheelchair. It also provides the opportunity for better circulation by allowing the user to change positions as often as the user wants which reduces the risk of skin excoriation.

Device Story

The Liberator is a standing wheelchair designed for paraplegic users; enables transition from seated to standing position while maintaining mobility. Device allows users to change positions independently to improve circulation and mitigate skin excoriation risks. Operated by the patient; used in home or community settings. Provides mechanical support for standing posture; no electronic or software components described.

Technological Characteristics

Mechanical standing wheelchair; manual operation; no electronic components, software, or energy sources described.

Indications for Use

Indicated for paraplegic patients requiring a wheelchair that enables standing while mobile; intended to facilitate position changes to improve circulation and reduce risk of skin excoriation.

Regulatory Classification

Identification

A standup wheelchair is a device with wheels that is intended for medical purposes to provide mobility to persons restricted to a sitting position. The device incorporates an external manually controlled mechanical system that is intended to raise a paraplegic to an upright position by means of an elevating seat.

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three lines representing its body and wings. The eagle is enclosed in a circle with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter of the circle.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

SEP 3 1999

Ms. Bonnie Bromley Vice President Liberator Wheelchairs, Inc. 7525 Parkwood Lane Ft. Worth, Texas 76133

Re: K984391 Trade Name: The Liberator Regulatory Class: II Product Code: IPL Dated: August 13, 1999 Received: August 17, 1999

Dear Ms. Bromley:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

{1}------------------------------------------------

## Page 2 - Ms. Bonnie Bromley

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at [phone]. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number [phone] or [phone] or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".

Sincerely yours,

Celia M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

510 (k) NUMBER (IF KNOWN) :K984391

The Liberator DEVICE NAME:

INDICATIONS FOR USE:

The Liberator wheelchair will be used for paraplegics to afford them the opportunity to be in a standing position while moving around in the wheelchair.

It also provides the opportunity for better circulation by allowing the user to change positions as often as the user wants which reduces the risk of skin excoriation.

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use (Per 21 CFR 801.109)

OR Over-The-Countery-Use
(Optional Format 1-2-96)

Pioella

(Division Sign-Off)
Division of General Restorative Devices K984391
510(k) Number